首页> 外文期刊>Regulatory peptides. >Involvement of the serotonergic system in orexin-induced behavioral alterations in rats.
【24h】

Involvement of the serotonergic system in orexin-induced behavioral alterations in rats.

机译:血清素能系统参与大鼠由orexin引起的行为改变。

获取原文
获取原文并翻译 | 示例
           

摘要

We have demonstrated involvement of the serotonergic system in orexin-induced behavioral responses in rats. Orexin-A and -B (hypocretin-1 and -2) significantly increased total locomotor activity when administered centrally. They also induced behavioral alterations; increasing grooming, face washing and wet dog shaking in rats. Haloperidol inhibited orexin-induced hyperlocomotion and these behavioral alterations. Serotonin antagonists, ritanserin and metergoline, did not attenuate orexin-induced hyperlocomotion but partly inhibited orexin-induced behavioral alterations. These results suggest that the dopaminergic system might be involved in orexin-induced hyperlocomotion, while both the serotonergic system as well as the dopaminergic system might be involved in orexin-induced behavioral responses.
机译:我们已证明血清素能系统参与了由orexin引起的大鼠行为反应。集中给药时,Orexin-A和-B(hypocretin-1和-2)显着增加了总运动能力。他们还诱发了行为改变;增加大鼠的美容,洗脸和湿狗晃动。氟哌啶醇抑制了由orexin引起的运动过度和这些行为改变。 5-羟色胺拮抗剂,利坦色林和美特古林不能减弱由orexin引起的运动过快,但可以部分抑制由orexin引起的行为改变。这些结果表明,多巴胺能系统可能与食欲素诱导的运动过度有关,而血清素能系统和多巴胺能系统均可能与食欲素诱导的行为反应有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号